-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Q05qj91y2Bo/Wg6D0GUPDht0WUAJbWTajfrUgJ0Q2RM3Iwcktw8+iTJeUkQx44DA XDu5MTot0l0BcFoPWke8RQ== 0001434913-10-000002.txt : 20100611 0001434913-10-000002.hdr.sgml : 20100611 20100611141854 ACCESSION NUMBER: 0001434913-10-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20100611 DATE AS OF CHANGE: 20100611 EFFECTIVENESS DATE: 20100611 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACT BIOTECH INC CENTRAL INDEX KEY: 0001434913 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-143366 FILM NUMBER: 10892295 BUSINESS ADDRESS: STREET 1: 717 MARKET STREET, SUITE 650 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 230-3901 MAIL ADDRESS: STREET 1: 717 MARKET STREET, SUITE 650 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 D 1 primary_doc.xml X0704 D LIVE 0001434913 ACT BIOTECH INC 717 MARKET STREET, SUITE 650 SAN FRANCISCO CA CALIFORNIA 94103 (415) 230-3901 DELAWARE None None Corporation true 2008 Wolf-Dieter Busse c/o ACT Biotech, Inc. 717 Market Street, Suite 650 San Francisco CA CALIFORNIA 94103 Executive Officer Director Ali Fattaey c/o ACT Biotech, Inc. 717 Market Street, Suite 650 San Francisco CA CALIFORNIA 94103 Executive Officer John Mahoney c/o ACT Biotech, Inc. 717 Market Street, Suite 650 San Francisco CA CALIFORNIA 94103 Executive Officer Georg Nebgen 369 Lexington Avenue, 17th Floor New York NY NEW YORK 10017 Director John Costantino 369 Lexington Avenue, 17th Floor New York NY NEW YORK 10017 Director Nils C. Behnke One Embarcadero Center, Suite 3500 San Francisco CA CALIFORNIA 94111 Director Biotechnology Decline to Disclose 06 false 2010-06-03 false true true true false 0 4000000 1000000 3000000 false 1 0 0 0 Proceeds from the offering will be used for general working capital. false ACT BIOTECH INC /s/ Ali Fattaey Ali Fattaey Chief Financial Officer 2010-06-09 -----END PRIVACY-ENHANCED MESSAGE-----